Post Holdings, Inc. — FY2023 Form 10-K
Reporting period: Fiscal year ended September 30, 2023. This is an annual report, not a standalone fourth-quarter report. Amounts are in U.S. dollars; financial statement amounts are in millions unless noted.
Business context
Post is a consumer packaged goods holding company with four reportable segments: Post Consumer Brands (cereal, pet food and nut butters), Weetabix (primarily U.K. cereal and related products), Foodservice (primarily eggs and potatoes) and Refrigerated Retail (side dishes, eggs, cheese and sausage). The April 2023 acquisition of Smucker’s pet food business added brands including Nutrish, Nature’s Recipe, 9Lives and Kibbles ’n Bits. BellRing is reported as discontinued operations for periods before its March 2022 spin-off.
Key financial results
| Metric | FY2023 | FY2022 |
|---|---|---|
| Net sales | $6,991.0 | $5,851.2 |
| Gross profit / margin | $1,881.7 / 26.9% | $1,467.5 / 25.1% |
| Operating profit / margin | $598.9 / 8.6% | $415.6 / 7.1% |
| Net earnings | $301.3 | $756.6 |
| Diluted EPS | $4.82 | $12.09 |
| Cash from continuing operations | $750.3 | $384.2 |
| Capital expenditures | $303.0 | $255.3 |
| Principal debt outstanding at year-end | $6,049.6 | $5,969.3 |
- Sales rose 19% and operating profit rose 44%. Growth included $679.8 of pet food sales for five months following the acquisition. Reported gross and operating margins improved despite input-cost inflation.
- Net earnings fell 60%, mainly reflecting much smaller non-operating gains than in FY2022: the BellRing investment gain was $5.1 versus $437.1, and income on swaps was $39.9 versus $268.0. The FY2023 results also included a $42.2 goodwill impairment charge.
- Operating cash flow increased $366.1 to $750.3. A simple operating-cash-flow-minus-capex measure was $447.3, compared with $128.9 in FY2022; this is not a company-reported free-cash-flow measure.
- Cash and cash equivalents were $93.3 at year-end, down from $586.5; restricted cash was $23.9. The $750.0 revolving facility had $730.3 available, net of letters of credit. Current assets were $1,478.5 and current liabilities $805.3.
- FY2023 financing included $387.1 of share repurchases and issuance of 5.4 million shares, valued at $492.3, to help fund the pet food acquisition. Net investing cash outflow was $669.3, including $715.2 paid for the acquisition, partly offset by the PHPC trust-account return.
Changes by segment
- Post Consumer Brands: Sales increased 35% to $3,033.1, primarily due to acquired pet food sales. Segment profit rose 20% to $378.8, while margin declined to 12% from 14%. Excluding pet food, volume fell 5%, with branded cereal weakness and growth in private-label cereal.
- Weetabix: Sales increased 7% to $512.1, but segment profit fell 33% to $73.9. Inflation and higher manufacturing costs more than offset pricing benefits; segment margin declined to 14% from 23%.
- Foodservice: Sales increased 16% to $2,425.9 and segment profit increased 131% to $349.5, reflecting pricing, volume gains, lower freight and comparison with prior-year legal costs. Inflation, including egg-related costs, remained a substantial offset.
- Refrigerated Retail: Sales declined 2% to $1,019.7; segment profit increased 21% to $69.2. Volumes were lower, including in cheese and dairy, while pricing and lower freight helped profit. Results included a $42.2 goodwill impairment in the Cheese and Dairy reporting unit.
Outlook, risks and unusual items
- Management expected input-cost inflation to continue into FY2024, but at a slower rate than FY2023 for domestic operations. Labor-cost pressure was also expected to continue. Pricing, cost savings and hedging had mitigated, but may not fully offset, cost increases.
- Management reported shifts toward private-label and value brands during FY2023 and expected the trend to continue in FY2024. The filing does not provide a clear numerical FY2024 earnings or sales guidance figure.
- On October 7, 2023, Post agreed to acquire Perfection Pet Foods for $235.0, subject to working-capital adjustments, expected to close in FY2024’s first quarter and be funded with cash and revolver borrowings.
- Post’s CEO was on medical leave beginning November 2, 2023; COO Jeff Zadoks was appointed interim CEO. The filing identifies leadership transition as a potential business and execution risk.
- Leverage is significant. The $400.0 incremental term loan carried a 7.67% rate at September 30, 2023. Post was in compliance with its financial covenants at year-end; the term-loan covenants include a secured net leverage limit of 4.25-to-1.00 and minimum interest coverage of 2.00-to-1.00.
- Goodwill totaled $4,574.4. Weetabix’s estimated fair value exceeded carrying value by approximately 6.4%; a 50-basis-point increase in its discount-rate assumption would, in isolation, put fair value 1.1% below carrying value. Further impairment is a risk if performance or assumptions deteriorate.
- Purchase commitments totaled $4,511.1, including $1,925.2 due in FY2024. Other key risks include major-customer concentration (Walmart was 17.3% of consolidated sales), commodity and supply-chain volatility, food safety, cybersecurity, competition, and high debt service needs.
- Bob Evans retained guarantees relating to restaurant-business leases on 130 properties; current annual rent was $13.1, with most leases extending about 14 years from year-end. Management considered the guarantees’ fair value immaterial. Management also said other pending legal matters were not expected to be material; the filing describes potential tax exposure if BellRing spin-off transactions fail to receive intended tax treatment.
Important facts for investors to verify
- Separate underlying operating performance from acquisition contributions and non-operating gains, particularly BellRing and swap-related items.
- Track pet food integration, expected synergies, transition-service dependence and the closing and financing of the Perfection acquisition.
- Monitor segment volumes, price elasticity and margins, especially Weetabix and Cheese and Dairy, alongside the stated impairment sensitivity.
- Review cash generation against acquisition spending, capital expenditures, repurchases, interest requirements, upcoming debt maturities and covenant headroom.
- Assess leadership continuity during the CEO’s medical leave and any subsequent management transition.